News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Alliances
RXi Pharmaceuticals (RXII) And Mirimmune LLC Enter Into An Exclusive Licensing Agreement For RXi's Self-Delivering RNAi (sd-rxRNA) Technology To Develop Cell-Based Immunotherapies To Treat Cancer 3/27/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/27/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/26/2015
Google (GOOG)'s Mystery Biotech Calico Cuts Local Longevity R&D Pact 3/26/2015
Helsinn Group Signs Exclusive Agreement With Mundipharma For Distribution And Licence Of Anamorelin In China, Hong Kong And Macao 3/26/2015
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015
Orion Corporation Signs Cooperation Agreement With HUCH Comprehensive Cancer Center 3/26/2015
CluePoints And ACRES Partner To Improve Data Quality In Clinical Research 3/26/2015
Probi Signs Agreement With Leading VMS Supplier In Canada 3/26/2015
Asahi Kasei Pharma (AHKSY.PK) Selects Evotec AG (EVTG.F) As Its Partner For Ion Channel Drug Discovery 3/26/2015
Evolva A/S And Valent BioSciences Corporation To Co-Develop Agricultural Bioactives 3/26/2015
Green Cross And Nanolek Announce Strategic Partnership For Biologics Commercialisation In Russia 3/26/2015
OXIS International, Inc. (OXIS) Biotech Executes Option Agreement To Certain Patents/Intellectual Properties Owned By The University of Pittsburgh 3/26/2015
Shire (SHPGY) And Cincinnati Children's Hospital Medical Center's Establish Rare Disease Research Collaboration 3/26/2015
Ablynx (ABLYF) Announces Extension Of Ion Channel Research Collaboration With Merck & Co. (MRK) 3/26/2015
MorphoSys AG And Celgene (CELG) Mutually Agree To End MOR202 Collaboration 3/26/2015
Recipharm AB And Adroit Science Form Collaboration To Expand Service Offering 3/26/2015
Merck & Co. (MRK) Announces Collaboration With American Diabetes Association To Educate Adults With Diabetes About Increased Risk For Serious Diseases Like Pneumococcal Pneumonia 3/26/2015
Lycera Announces Milestone In Merck & Co. (MRK) Collaboration 3/25/2015
Signum Dermalogix Out-Licenses SIG990 To Dermata Therapeutics For Topical Treatment of Rosacea 3/25/2015
Novasep And Celladon Corporation Execute MYDICAR API Supply Agreement 3/25/2015
Avalanche Biotechnologies (AAVL) And The University of Washington Enter Into Exclusive License Agreement To Develop Gene Therapy Medicines To Treat Color Blindness 3/25/2015
Bellerophon Therapeutics (BLPH) Selects Flextronics (FLEX) To Manufacture The Mark2, Next-Generation Inopulse Device 3/25/2015
Phosphagenics Limited (POH.AX) Signs License Agreement To Expand TPM-Based Animal Nutrition Products To The UK And Ireland 3/25/2015
Cancer Research UK Cambridge Research Institute And Medidata Solutions, Inc. Partner To Streamline Data Collection And Management For Cancer Clinical Trials 3/25/2015
The Institut Pasteur Announces An Alliance With Integragen To Strengthen Its High-Throughput Sequencing Activities In Microbiology 3/25/2015
Taconic Biosciences And Cellaria Biosciences Agree To Scientific Collaboration To Facilitate Xenograft Use In Oncology Research 3/25/2015
Emergent BioSolutions (EBS) Awarded $31 Million Contract For Advanced Development Of Nuthrax, A Next Generation Anthrax Vaccine 3/24/2015
Biocept, Inc. (BIOC) Enters Clinical Collaboration With University of California, San Diego (UCSD) Moores Cancer Center 3/24/2015
USPTO Issues Positive Decision That Triggers Royalty Payments To Neptune Technologies & Bioressources Inc. 3/24/2015
TB Alliance Announces Partnership With U.S. Fund For UNICEF To Increase Access To Impending New Child-Friendly TB Treatments 3/24/2015
Denator AB Enters Into Collaboration With Newly Established State-Of-The-Art European Institute For Clinical Applications 3/24/2015
Mercachem Choose Cresset’s Torch And Spark Molecule Design Software To Support Their Growing Medicinal Chemistry Service Business 3/24/2015
ABL Awarded National Cancer Institute Contract To Continue Groundbreaking Retroviral Research 3/24/2015
Ocata Therapeutics Licenses Induced Pluripotent Stem Cell Technology From Allele Biotechnology And Extends Leadership Position In Cell Therapy Capabilities 3/24/2015
Qu Biologics Begins Research Collaboration With University of Rochester, New York 3/24/2015
Probi AB And Wageningen University Enter Long-Term Research Collaboration 3/24/2015
Portage Biotech's Biohaven Enters Into Exclusive Formulation Agreement And Global License With Catalent Pharma Solutions (CTLT) For Lead Product 3/24/2015
Affimed Therapeutics AG (AFMD) Completes Tandab Development Candidate Activities Meeting Amphivena's And Janssen Biotech Inc. (JNJ)'s Criteria And Achieves Milestone Ahead Of Schedule 3/24/2015
Stemedica Cell Technologies, Inc. Obtains An Exclusive Worldwide License For Stem Cell Stabilization And Preservation Technologies 3/24/2015
ImmunoGen (IMGN) Jumps After Reaching $220 Million Cancer Deal With Takeda (TKPYY) 3/23/2015
Another Day, Another $456 Million Cancer Pact for Eli Lilly (LLY) 3/23/2015
Clontech Laboratories, Inc. Signs Agreement With Ludwig Cancer Research For Access To Smart-Seq2 3/23/2015
Pfizer (PFE) Pockets $200 Million as Tanezumab Phase III Program With Eli Lilly (LLY) Resumes 3/23/2015
Can-Fite BioPharma (CFBI) Signs Multi-Million Dollar Distribution Agreement For CF101 In Canada With Cipher Pharmaceuticals (DND.TO) 3/23/2015
GenVec Inc. (GNVC) And TheraBiologics Form Collaboration To Develop Neural Stem Cell Mediated Cancer Therapies 3/23/2015
Yew Bio-Pharm Group Signs Sales Agreement And Receives Subsidy Grant From The Finance Department Of Heilongjiang Province, China 3/23/2015
Prime Therapeutics Selects EQuIPP As Platform For Collaboration With Community Pharmacies For Continuous Improvement Of Quality 3/23/2015
Week In Review: China's Innovent And Eli Lilly (LLY) Form $456 Million Cancer Biologics Alliance 3/23/2015
Zai Lab In-licenses Potential Liver Cancer Drug From Bristol-Myers Squibb (BMY) 3/23/2015
Cold Spring Harbor Laboratory And GlaxoSmithKline (GSK) To Develop Diabetes And Obesity Therapeutic 3/23/2015
Horizon Discovery Group plc And ArcherDX Sign OEM Agreement 3/23/2015
ICON And Carnegie Mellon University Collaborate to Evaluate Patient-Centric Informed Consent Processes 3/23/2015
ISA Scientific, Yissum Ltd., Hadasit Ltd., And The Kennedy Trust For Rheumatology Research To Collaborate On Treating Diabetes And Other Serious Health Conditions With Cannabidiol 3/23/2015
Confluence Pharmaceuticals Signs Co-Development And Marketing Agreement With AOP Orphan Pharmaceuticals AG For Fragile X Syndrome Drug 3/23/2015
Evotec AG (EVTG.F) Inherits Sanofi (SAN.PA)'s Troubled Division in €250 Million Long Term Drug Discovery Deal 3/20/2015
Celgene (CELG)'s Deal-Making Guru About to Find Out If His Strategy Works or Not 3/20/2015
Intarcia Therapeutics, Inc. And Numab AG Sign Multi-Asset Collaboration To Develop Once-Yearly Therapies In Diabetes, Obesity, and Autoimmune Indications 3/20/2015
Vaccinex, Inc. Signs Multi-Target Antibody Discovery Deal With Five Prime Therapeutics, Inc. (FPRX) 3/20/2015
New England Biolabs, Inc. And Benchling Collaborate To Simplify Golden Gate Assemblies 3/20/2015
The Dow Chemical Company (DOW) Expands Partnership With FIRST To Promote STEM Education 3/20/2015
ImmunoCellular Therapeutics, Ltd (IMUC) Chooses PharmaCell As Contract Manufacturing Partner For Its Phase III Program In Europe 3/20/2015
National Institute For Occupational Safety And Health Partners With Protea Biosciences, Inc. 3/20/2015
The Cooperative Research Centre for Cell Therapy Manufacturing Release: International Regenerative Medicine Groups Form Strategic Alliance To Commercialize Cell Therapies 3/20/2015
AstraZeneca PLC (AZN), Daiichi Sankyo (DSNKY) in $825 Million Drug Tie-Up 3/19/2015
Eli Lilly (LLY), Hanmi Pharma Forge $690 Million Autoimmune Pact 3/19/2015
ImmunoCellular Therapeutics, Ltd (IMUC) Establishes Manufacturing Agreement With Pharmacell B.V. For European Production Of ICT-107 For Phase 3 Registration Trial 3/19/2015
Sigma-Aldrich Corporation (SIAL) Announces Exclusive Distribution Agreement With Roche (RHHBY) 3/19/2015
AbbVie (ABBV) And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy 3/19/2015
Coronado Biosciences (CNDO) Announces Exclusive Licensing Agreement With Neupharma To Develop And Commercialize Novel Covalent 3rd Generation EGFR Inhibitors 3/19/2015
GAP And IMI To Sign MOU To Accelerate Alzheimer's Drug Development 3/19/2015
Cydan Supports Innovation For Patients With Rare Diseases Through MassChallenge Scholarships 3/19/2015
Easton Pharmaceuticals (OP: EAPH) Announces North American Products Distribution And Intellectual Property Agreement With Nutrashop Global Stores, A Large Online Quality Wellness And Therapeutic Products Retailer; Provides Other Updates 3/19/2015
Stevia First Corp. Announces Scientific Collaboration With BioViva Sciences 3/19/2015
Big Names Such as GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), and Pfizer (PFE) Invest in $100 Million Alzheimer's Venture Fund 3/18/2015
Gentronix Limited Announces Multi-Year Agreement For Provision Of GreenScreen HC Technology To Major Chinese Research Institute, Shanghai Institute Of Materia Medica 3/18/2015
TaiGen Biotechnology Announces Burixafor Collaboration With Celldex (CLDX) And The University Hospital Carl Gustav Carus Dresden In Germany 3/18/2015
Lexicon Pharmaceuticals, Inc. (LXRX) And Ipsen (IPN.PA) Expand Their Licensing And Commercialization Agreement For Telotristat Etiprate To Include Canada 3/18/2015
St. George's University And Rutgers University Launch Joint Veterinary Partnership 3/18/2015
PsychoGenics Inc. Obtains A License To ?-Synuclein Transgenic Mouse Models Of Parkinson's Disease 3/18/2015
SYGNIS Signs Non-Exclusive Distribution Agreement With SOPACHEM For Trueprime Product Family In Belgium 3/18/2015
ProtoKinetix Inc. (PKTX.OB) Announces Consulting Agreements 3/18/2015
Open Monoclonal Technology, Inc. Grants OmniAb License To University of Nottingham 3/18/2015
Spotlight Innovation Enters Into Purchase Agreement With Memcine Pharmaceuticals 3/18/2015
MR Solutions Now Provides Maintenance And Upgrade Support For Agilent Technologies Inc. (A) And Other Preclinical Scanners 3/18/2015
Galapagos (GLPG.BR) Ends Long-Running R&D Inflammation Pact With Janssen Pharmaceutica N.V. 3/17/2015
VALNEVA Announces Signing Of An Exclusive License Agreement On EB66 Cell Line For Human And Veterinary Vaccines In China 3/17/2015
Celldex (CLDX) Announces Clinical Trial Collaboration With Roche (RHHBY) To Evaluate The Combination Of Varlilumab And MPDL3280A 3/17/2015
Ferndale Healthcare Supports The Colon Cancer Alliance With RectiCare Partnership 3/17/2015
Myriad Genetics, Inc. (MYGN) And BioMarin (BMRN) Expand Collaboration To Evaluate Mychoice HRD As A Companion Diagnostic For Talazoparib 3/17/2015
Genedata AG Partners With Bayer Pharma AG On Innovative Workflow Platform For High-Throughput Cell Line Development 3/17/2015
Egalet Earns $10 Million Milestone Payment Triggered By Advancement Of Shionogi, Inc.'s Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's GuardianTechnology 3/17/2015
GlaxoSmithKline (GSK) Selects Veeva Systems, Inc. As Global Multichannel CRM Partner 3/17/2015
BioInvent (BOVNF) Announces Plan To Initiate Clinical Development Of TB-403 In Pediatric Cancer Together With ThromboGenics Ltd. (THR.BR) 3/17/2015
Taconic Biosciences Strengthens Japanese Distribution And Breeding Partnerships 3/17/2015
Boston Therapeutics, Inc. And Advance Pharmaceutical Expand Sugardown Licensing Agreement To Japan; Increases Number Of Asian Countries To 16 3/17/2015
Cloud Pharmaceuticals, Inc. And The University of Florida Department Of Medicine Collaborate On The Rapid Design Of Novel Cancer Inhibitors 3/17/2015
Tauriga Sciences Inc. (TAUG) And Breathe ECig Corp. Enter License Agreement To Co-Develop And Co-Commercialize New CBD E-Cigarette 3/16/2015
Emergent BioSolutions (EBS) Signs Agreements With Oxford University, GlaxoSmithKline (GSK), And National Institute of Allergy And Infectious Diseases (NIAID) For The Production Of An MVA Ebola Zaire Vaccine Candidate 3/16/2015
NantWorks And Sorrento Therapeutics, Inc. Announce Second Comprehensive Global Collaboration On Discovery And Development Of Novel Anti-Cancer Immunotherapies 3/16/2015
NTT Medical Center Tokyo And UBIC Conduct Joint Research On AI-Based System To Mitigate Patients' Risk Of Falling 3/16/2015
Eppendorf AG And Florida State University Collaboration Demonstrates Large-Scale Stem Cell Expansion 3/16/2015
ARTES Biotechnology And Boehringer Ingelheim Animal Health Announce Collaboration 3/16/2015
Kerafast And The Wistar Institute Announce Collaboration Through The Kerafast Fellows Program 3/16/2015
Macrophage Therapeutics, A Subsidiary Of Navidea Biopharmaceuticals (NAVB), Executes Securities Purchase Agreement For $2.5 Million Financing And Receives Initial Funding 3/16/2015
SCIEX Announces OneOmics Collaborators 3/16/2015
Helix Biopharma (TSX:HBP) Announces The Receipt Of Subscription Agreements For A Net CAD5.2 Million Private Placement 3/16/2015
Second Genome And Evotec AG (EVTG.F) To Collaborate In Microbiome Discovery And Development 3/13/2015
Led By a Serial Biotech Entrepreneur, Kura Oncology Forges Pact With Johnson & Johnson (JNJ) Unit and Bags $60 Million to Work on Shelved Drug 3/13/2015
T-Bird Pharma Inc. Announces Partnership With Medna Biosciences Inc. 3/12/2015
Oxis Biotech Licenses Rights To Antibody-Drug Conjugates For The Treatment Of Cancer 3/12/2015
bioskin And Modoc Research Services, Inc. Announce Strategic Alliance To Expand Global Service Offerings 3/12/2015
Lakewood-Amedex Inc. Announces Expanded Research Collaboration With The University Of Jyvaskyla Following Promising Results Demonstrating Bisphosphocin Activity Against Borrelia Burgdorferi 3/12/2015
MultiCell Immunotherapeutics, Inc. And Oxis Biotech Sign Antibody-Drug Conjugate R&D, Product License And Commercialization Agreement 3/12/2015
Society For Clinical Research Sites Expands Relationship With Acurian, Inc. As First Site Engagement Partner 3/12/2015
Vigilant Biosciences Announces Agreement With Biotech-Igg AB For Exclusive Distribution Of The OncAlert Oral Cancer Risk Assessment System In Scandinavia 3/11/2015
Shanghai Pharmaceutical Co., Ltd. Forms Online Drug Distribution JV 3/11/2015
Transgenomic, Inc. (TBIO) Expands License Agreement With Exiqon A/S To Support Global Commercialization Of Its Multiplexed ICE COLD-PCR For Cancer Liquid Biopsies 3/11/2015
Open Monoclonal Technology, Inc. Announces OmniAb Alliance With Celgene (CELG) 3/11/2015
Spotlight Innovation Subsidiary Celtic Biotech Iowa Licenses Promising Therapy For Chronic Kidney Disease 3/11/2015
Illumina (ILMN) Announces Strategic Collaboration With Merck Serono To Expand Companion Diagnostics For Oncology 3/10/2015
Halozyme Therapeutics, Inc. (HALO) Reports Selection Of First Product Candidate Under Janssen Biotech Inc. (JNJ) Collaboration 3/10/2015
MedImmune (AZN) And Joslin Diabetes Center Announce New Research Collaboration Focused On Advancing Metabolic Disease Research 3/10/2015
Toolgen And Thermo Fisher Scientific (TMO) Sign License Agreement For CRISPR/Cas9 Genome Editing Technology 3/10/2015
PDS Life Sciences Helps Major Pharma Company Receive The First FDA Acceptance Of A BLA Filing Incorporating SEND Requirements 3/10/2015
SYGNIS AG Signs Non-Exclusive Distribution Agreement For Trueprime Product Family With OZYME France 3/10/2015
InMed Forms Strategic Collaboration To Develop Novel Phytocannabinoid Therapies For Ocular Allergies 3/10/2015
14M Genomics And The European Organization For Research And Treatment Of Cancer Collaborate On Genomic Profiling For Clinical Trials 3/10/2015
NRGene And International Researchers Team To Map Key Wheat Genome 3/10/2015
Sage Bionetworks And The Michael J. Fox Foundation Collaborate To Amplify Parkinson’s Patient Voice In Research 3/10/2015
EMD Serono And Opexa Therapeutics (OPXA) Amend Agreement To Support Ongoing Development Of Tcelna (Imilecleucel-T) For Multiple Sclerosis 3/9/2015
Epic Sciences And The Prostate Cancer Clinical Trials Consortium Collaborate To Advance Therapeutic Development 3/9/2015
Innate Pharma (IPH.PA ) Collaborates With NCIC Clinical Trials Group On The Phase I/II Trial Of IPH2201 In Ovarian Cancer 3/9/2015
Sucampo Pharmaceuticals, Inc. (SCMP) To Return All Licenses For Unoprostone Isopropyl To R-Tech Ueno 3/9/2015
Hemispherx Biopharma (HEB) Enters A Collaboration With Emerge Health For The Commercialization Of Ampligen For Chronic Fatigue Syndrome (CFS) In Australia And New Zealand 3/9/2015
EXACT Sciences Corporation (EXAS) And Ironwood Pharmaceuticals (IRWD) Enter Co-Promotion Agreement For Cologuard 3/9/2015
Interleukin Genetics Inc. (ILGN) Expands Its Collaboration With Isis Pharmaceuticals, Inc. (ISIS) For Genetic Testing Services 3/9/2015
Hanmi Pharmaceutical, Co., Ltd To Assign The Rights Of The Indian Territory To Kinex Pharmaceuticals As Part Of The Orascovery Program Strategic Plan 3/9/2015
CROS NT Extends DATATRAK International, Inc. (DATA) CONNECT Partnership 3/9/2015
Enumeral Biomedical (ENUM) And The Ragon Institute Of MGH, MIT And Harvard University To Research Human Mucosal Immunology With Immune Profiling System 3/9/2015
Pharmaco-Kinesis Corporation And The Ohio Clinical Trials Collaborative Consider Strategic Partnership To Develop Cloud-Linked Biosensors 3/9/2015
Opexa Therapeutics (OPXA) Amends Agreement With Merck Serono And Receives Additional $3 Million Payment To Support Ongoing Development Of Tcelna For Multiple Sclerosis 3/9/2015
NovaBay Pharmaceuticals, Inc. (NBY) Signs Avenova And NeutroPhase Distribution Agreements 3/9/2015
Altasciences And ITR Laboratories Form A Strategic Alliance 3/9/2015
Pfenex (PFNX) Exercises Glide Contract Extension For Solid Dose Formulation Of Recombinant Protective Antigen (rPA)-Based Anthrax Vaccine 3/9/2015
Calithera Biosciences, Inc. (CALA) Gains Exclusive, Worldwide License To TransTech Pharma, Inc.'s Hexokinase II Inhibitor Program 3/6/2015
Isis Pharmaceuticals, Inc. (ISIS) Earns $9 Million For Advancing ISIS-SMN Rx In Infants With Spinal Muscular Atrophy 3/6/2015
Vernalis PLC (VNLPY.PK) And Asahi Kasei Pharma (AHKSY.PK) Achieve Research Milestone 3/6/2015
ModiQuest Research And Cellectis (ALCLS) To Collaborate On Antibody Generation For Potential CAR Development 3/6/2015
Midatech Pharma Plc Release: Research Collaboration Signed With Global Pharmaceutical Company 3/6/2015
Navidea Biopharmaceuticals (NAVB) And Norgine Enter European Commercial Partnership For Lymphoseek; Navidea To Receive $2 Million Upfront Payment 3/5/2015
Eisai Company, Ltd. (ESALY.PK) And Merck & Co. (MRK) Enter Collaboration To Explore Novel Combination Regimens Of Anti-PD-1 Therapy With Multi-Targeting RTK Inhibitor And Microtubule Dynamics Inhibitor In Multiple Types Of Cancer 3/5/2015
ABC Laboratories, Inc. And Immunophotonics Announce Deeper Development Partnership 3/5/2015
St. George's University And King's College Announce Seven-Year Medical And Veterinary Education Partnerships 3/5/2015
Altasciences And ITR Laboratories Form A Strategic Alliance 3/5/2015
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine 3/5/2015
New Jersey Startup Celimmune Aims to Give New Life to Shelved Amgen (AMGN) Drug 3/4/2015
AstraZeneca PLC (AZN), University of Cambridge in Tie-Up to Identify, Train, and Mentor Biotech Startups 3/4/2015
Tauriga Sciences Inc. (TAUG) Expands Agreement With Targeted Medical Pharma 3/4/2015
Centene Corporation's Missouri Subsidiary Announces Successful Reprocurement Of Managed Care Contract 3/4/2015
BioClinica, Inc. Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3/4/2015
TG Therapeutics, Inc. (MHA) Enters Into A Global Collaboration With Checkpoint Therapeutics To Develop And Commercialize Novel Immuno-Oncology Targeted Antibodies 3/4/2015
Resverlogix Corporation (RVX.TO) Collaborates With Emerald Logic To Identify Factors Driving Drug Response And Efficacy In Phase 2 Program 3/4/2015
SYGNIS AG Signs Initial Distribution Agreement For The Asian Market For The Trueprime Product Family With Japanese Funakoshi Co. 3/4/2015
Domain Therapeutics Launches Specific Purpose Vehicle Kaldi Pharma To Harness The Potential Of Its Adenosine Programs 3/4/2015
Synpromics Announces New Collaboration In AAV Based Gene Therapy Vector Development 3/4/2015
Eli Lilly (LLY) And Indiana University School of Medicine Partner On Rotation Program For Medical Students 3/4/2015
PerkinElmer, Inc. (PKI) Collaborates With Johnson & Johnson (JNJ) Innovation To Provide Resources And Expertise To JLABS @South San Francisco 3/4/2015
Spectrum Pharmaceuticals, Inc. (SPPI) In-Licenses Poziotinib, A Novel pan-HER Inhibitor With Clinical Activity In Several Solid Tumors, From Hanmi Pharmaceutical, Co., Ltd 3/4/2015
VWR, Inc. Announces Expansion Of Distribution Agreement With New England Biolabs, Inc. 3/3/2015
Pulmokine Receives $1 Million Investment From Broadview Ventures To Advance PAH Candidate Into First Clinical Trial 3/3/2015
Islet Sciences Enters Into Exclusive License Agreement For Phase 2 SGLT2 Inhibitor Remogliflozin Etabonate 3/3/2015
Fidelta Achieves Milestone In Collaboration With LEO Pharma 3/3/2015
Genedata Biologics Licensed By Pfizer (PFE) 3/3/2015
Regenicin (RGIN) Receives $2.3 Million In Final Payment From Amarantus 3/3/2015
Cerulean Pharma Inc. (CERU) Establishes Clinical Collaboration With The GOG Foundation To Study CRLX101 In Combination With Weekly Paclitaxel In Relapsed Ovarian Cancer 3/3/2015
Blueprint Medicines Strikes $265 Million Deal With Alexion Pharmaceuticals Inc. (ALXN) 3/3/2015
Exostar & DocuSign Partner to Help Life Sciences and Healthcare Organizations Go 100% Digital 3/3/2015
New Projects For Image Interpretation And Management In Clinical Trials Totaling €1.53M For MEDIAN Technologies 3/3/2015
ISA Pharmaceuticals Signs R&D Agreement With Shin Nippon Biomedical Laboratories 3/3/2015
Akili Interactive Labs Announces Clinical Collaboration Agreement With Autism Speaks' Affiliate DELSIA LLC 3/2/2015
Athersys, Inc. (ATHX) And Chugai Pharmaceutical Co., Ltd. (Japan) Enter License Agreement And Collaboration To Develop Multistem Cell Therapy For Ischemic Stroke In Japan 3/2/2015
Genmab A/S (GEN.CO) Announces That Agreement To Transfer Ofatumumab Collaboration To Novartis AG (NVS) Is Now Effective 3/2/2015
Kite Pharma (KITE) Expands Its Research And Development Collaboration With The National Cancer Institute To Develop A Next Generation Of Cancer Immunotherapy Products For Solid Tumors 3/2/2015
Stand Up To Cancer Release: EHE International Joins Forces With Stand Up To Cancer And Genentech (RHHBY) To Raise Awareness, Stress Importance Of Supporting Research 3/2/2015
Suneva Medical Selects Crown Bioscience, Inc. To Co-Promote ReFissa 3/2/2015
SCIEX And Labor Berlin Collaboration To Advance Forensic Testing 3/2/2015
Resilience And PsychoGenics Inc. Announce A Drug Discovery Partnership 3/2/2015
PharMerica Announces Wholesale Drug Distribution Agreement With Cardinal Health (CAH) 3/2/2015
Crohn's and Colitis Foundation of America Release: Three Research Leaders Join Forces To Study Diet's Role In Inflammatory Bowel Diseases 3/2/2015
Isis Pharmaceuticals, Inc. (ISIS) Earns $15 Million From GlaxoSmithKline (GSK) for Advancing ISIS-TTR Rx 3/2/2015
The Black AIDS Institute In Partnership With Novant Health Brings Health Screenings To Black College Students At CIAA 2/27/2015
Cerus Corporation (CERS) Signs INTERCEPT Platelet Agreement With Sweden’s Largest Blood Product Supplier 2/27/2015
Clinigen Group Signs Distribution Agreement With MSD UK For Clinical Trial Supply Services 2/27/2015
Triphase Accelerator Enters Into Academic Center Collaboration With Sunnybrook Research Institute To Advance Development Of Bi-Specific Antibody In The Interest Of Cancer Patients 2/27/2015
How Merck & Co. (MRK)'s R&D Chief Saved NGM Deal With a Juicy Pitch 2/27/2015
Eddingpharm Gains China Rights To Amarin (AMRN)'s Omega-3 Product In $169 Million Deal 2/27/2015
AstraZeneca PLC (AZN) Taps Startup for $122.5 Million Autoimmune Pact 2/26/2015
Vernalis PLC (VNLPY.PK) Licenses Proprietary ARA Technology 2/26/2015
Peak Pharmaceuticals Contracts With GMP Compliant Manufacturer 2/26/2015